Status:
UNKNOWN
Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Actinic Keratosis
Lead Sponsor:
Shanghai Dermatology Hospital
Conditions:
Actinic Keratosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is being done to compare a new, continuous illumination and short Incubation time regimen of aminolevulinic acid photodynamic therapy#ALA-PDT) to a conventional regimen for treatment of Act...
Detailed Description
This study is being done to compare a new, continuous illumination and short Incubation time regimen of aminolevulinic acid photodynamic therapy#painless-PDT) to a conventional regimen for treatment o...
Eligibility Criteria
Inclusion
- Clinical diagnosed with AK (OLSEN classification grade I, II, III), aged \> 18 years (Because no dosing or adverse event data are currently available on the use of topical aminolevulinic acid in patients \<18 years of age, children are excluded from this study);
- All patients are unfit and reluctant to undergo surgery for any reasons, and volunteered to participate in the study and ability to understand and the willingness to sign a written informed consent. Patents are willing to pay for the treatment, and agreed to take a picture of the skin lesions.
Exclusion
- Those who had ALA-PDT and any other studies that affect this study within 12 weeks ;
- There are other facial diseases that may affect the efficacy evaluation, such as other photodermatosis;
- Take phototoxic or photosensitizer within 8 weeks;
- Clinical and / or pathological prove that the tumor has invaded other organs or tissues;
- Serious immunocompromised persons;
- scar constitution;
- Patients are known to have skin photosensitivity, porphyria, or allergies to ALA, light or lidocaine;
- Persons are suffering from severe internal diseases, mental and mental illness, infectious diseases or pregnant or lactating women.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04396184
Start Date
May 1 2020
End Date
April 30 2021
Last Update
May 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yunfeng Zhang
Shanghai, Jinan, China, 200443